Triasima Portfolio Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Triasima Portfolio Management's AMGN Position: Q1 2025 in Review
Triasima Portfolio Management sold out of Amgen (AMGN) in Q1 2025, closing a stake of 4,244 shares — an estimated $1.11M sold.
Triasima Portfolio Management first reported a position in AMGN in Q4 2020 and held it in 5 quarters. The position peaked at $3.67M in Q3 2024. 2,926 funds tracked by Wall St. Rank hold AMGN as of Q1 2025.
- Triasima Portfolio Management reported no remaining Amgen position as of Q1 2025 after selling out during the quarter.
- Triasima Portfolio Management sold 4,244 Amgen shares in Q1 2025, an estimated $1.11M.
- Triasima Portfolio Management first reported a position in Amgen in Q4 2020 and held it in 5 quarters.
- Triasima Portfolio Management's Amgen position peaked at $3.67M in Q3 2024.
- 2,926 funds tracked by Wall St. Rank held Amgen as of Q1 2025.
Based on Triasima Portfolio Management's 13F filing for Q1 2025, filed 2 May 2025.